ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials Life Science Investing
Rain Enhancement Technologies Exhibits at Premier WMO Scientific Conference, Showcases Ionization Research Advancements Life Science Investing
MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer Meeting Life Science Investing
Lexston Mining Corporation Announces Marketing Consulting Services Agreement with Spark Newswire Inc. Life Science Investing
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025 Life Science Investing
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression Psychedelics Investing
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting Life Science Investing
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 Life Science Investing
Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules Life Science Investing
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 Life Science Investing
